Background The caninised monoclonal antibody lokivetmab (LKV), directed at interleukin (IL)‐31, is very effective at controlling pruritus in most dogs with atopic dermatitis (AD). However, evidence exists that IL‐31 is not required for the induction of acute allergic skin inflammation, which might explain why this treatment is less efficacious in some dogs with AD. Hypothesis/Objectives To compare the comprehensive transcriptome analysis of house dust mite (HDM)‐sensitised dogs with and without treatment with LKV to attest our hypothesis that LKV does not majorly affect acute cytokine/chemokine production. Animals Six HDM‐sensitised atopic Maltese‐beagle dogs. Materials and Methods In this cross‐over study, the cytokine profiling of acute AD skin lesions was compared by RNA sequencing (RNA‐Seq), with or without LKV‐induced inhibition of IL‐31. Skin biopsies were obtained from each dog at 0, 6, 12, 24, 48, and 96 h after epicutaneous HDM allergen provocation. Results Macroscopic and microscopic skin lesion scores were not significantly different between the LKV‐ and nontreatment groups at any time points. Likewise, the results of RNA‐Seq analysis revealed no significant difference in the messenger (m)RNA expression of the major cytokines between these two groups. In LKV‐treated dogs, IL6, IL9, IL13, IL33, CCL17, and CCL22 were significantly upregulated compared to their baseline expression levels, suggesting that these cytokines are unaffected by IL‐31 inhibition. Conclusions and Clinical Relevance IL‐31 inhibition is insufficient to prevent the expression of other proinflammatory mediators in acute AD and these could be considered as other potential therapeutic targets.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.